RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
USANA Health Sciences - Stock

USANA Health Sciences P/E 2024

USANA Health Sciences P/E

17.49

Ticker

USNA

ISIN

US90328M1071

WKN

923145

As of Jun 26, 2024, USANA Health Sciences's P/E ratio was 17.49, a -5.87% change from the 18.58 P/E ratio recorded in the previous year.

The USANA Health Sciences P/E history

USANA Health Sciences Aktienanalyse

What does USANA Health Sciences do?

USANA Health Sciences Inc is an American company that was founded in 1992 by Dr. Myron Wentz. Originally headquartered in Salt Lake City, Utah, the company now operates in over 20 countries worldwide. The main mission of USANA is to help people live healthier lives through high-quality supplements and a healthy lifestyle. USANA is a direct sales company, which means that its products are sold by independent distributors. These distributors earn a commission on their sales and can also have additional income opportunities by building a network of distributors. USANA's business model is based on the idea that people can improve their well-being and enhance their lives by using high-quality supplements and adopting a healthy lifestyle. USANA offers a wide range of products in various categories, including supplements for adults and children, weight management products, personalized vitamins and minerals, skincare products, as well as energy and fitness products. The quality of USANA's products is ensured through strict quality assurance measures and independent certification by NSF International, a third-party company that verifies the safety and efficacy of supplements. USANA also has several divisions, including USANA Health Sciences, Inc., USANA Pacific, Ltd., and BabyCare Ltd. USANA Health Sciences, Inc. is the company's main focus, specializing in the development and distribution of health-related products. USANA Pacific Ltd. is a wholly independent company that focuses on developing and distributing products for customers in Australia, New Zealand, and Asia. BabyCare Ltd. is a company specialized in manufacturing skincare products for babies. USANA has also established a charitable organization, the USANA Foundation, to carry out philanthropic work in various communities around the world. The USANA Foundation addresses basic needs such as health, education, and nutrition and supports organizations dedicated to helping children in need. In summary, USANA Health Sciences Inc is a company that is dedicated to improving people's health and well-being. Its direct sales model and use of high-quality ingredients and supplements certified by an independent third party have helped to build consumer trust in USANA's products. USANA has also expanded its reach through the establishment of various divisions and the creation of a charitable organization, allowing it to have a positive impact on many people worldwide. USANA Health Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering USANA Health Sciences's P/E Ratio

The Price to Earnings (P/E) Ratio of USANA Health Sciences is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing USANA Health Sciences's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of USANA Health Sciences is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in USANA Health Sciences’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about USANA Health Sciences Stock

What is the price-to-earnings ratio of USANA Health Sciences?

The price-earnings ratio of USANA Health Sciences is currently 17.49.

How has the price-earnings ratio of USANA Health Sciences changed compared to last year?

The price-to-earnings ratio of USANA Health Sciences has increased by -5.87% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of USANA Health Sciences high compared to other companies?

Yes, the price-to-earnings ratio of USANA Health Sciences is high compared to other companies.

How does an increase in the price-earnings ratio of USANA Health Sciences affect the company?

An increase in the price-earnings ratio of USANA Health Sciences would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of USANA Health Sciences affect the company?

A decrease in the price-earnings ratio of USANA Health Sciences would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of USANA Health Sciences?

Some factors that influence the price-earnings ratio of USANA Health Sciences are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does USANA Health Sciences pay?

Over the past 12 months, USANA Health Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, USANA Health Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of USANA Health Sciences?

The current dividend yield of USANA Health Sciences is .

When does USANA Health Sciences pay dividends?

USANA Health Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of USANA Health Sciences?

USANA Health Sciences paid dividends every year for the past 0 years.

What is the dividend of USANA Health Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is USANA Health Sciences located?

USANA Health Sciences is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von USANA Health Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of USANA Health Sciences from 6/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/26/2024.

When did USANA Health Sciences pay the last dividend?

The last dividend was paid out on 6/26/2024.

What was the dividend of USANA Health Sciences in the year 2023?

In the year 2023, USANA Health Sciences distributed 0 USD as dividends.

In which currency does USANA Health Sciences pay out the dividend?

The dividends of USANA Health Sciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von USANA Health Sciences

Our stock analysis for USANA Health Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of USANA Health Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.